These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32974185)

  • 21. Corrigendum: A Non-invasive Method to Diagnose Lung Adenocarcinoma.
    Yan M; Wang W
    Front Oncol; 2020; 10():1515. PubMed ID: 32983996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [c-Met and HGF expression in non-small-cell lung carcinomas].
    Korobko IV; Zinov'eva MV; Allakhverdiev AK; Zborovskaia IB; Svwrdlov ED
    Mol Gen Mikrobiol Virusol; 2007; (2):18-21. PubMed ID: 17598453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HGF induces EMT in non-small-cell lung cancer through the hBVR pathway.
    Liu F; Song S; Yi Z; Zhang M; Li J; Yang F; Yin H; Yu X; Guan C; Liu Y; Liu Z; Wang J; Zhu D
    Eur J Pharmacol; 2017 Sep; 811():180-190. PubMed ID: 28554854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum: Machine learning in non-small cell lung cancer radiotherapy: a bibliometric analysis.
    Zhang J; Zhu H; Wang J; Chen Y; Li Y; Chen X; Chen M; Cai Z; Liu W
    Front Oncol; 2023; 13():1197217. PubMed ID: 37143938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells.
    Zhou H; Liu M; Shao T; Xie P; Zhu S; Wang W; Miao Q; Peng J; Zhang P
    Front Oncol; 2022; 12():1032265. PubMed ID: 36212453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells.
    Nishimura Y; Hyuga S; Takiguchi S; Hyuga M; Itoh K; Hanawa T
    Int J Oncol; 2016 May; 48(5):1895-906. PubMed ID: 26983447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrigendum: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway.
    Jain AS; Prasad A; Pradeep S; Dharmashekar C; Achar RR; Silina E; Stupin V; Amachawadi RG; Prasad SK; Pruthvish R; Syed A; Shivamallu C; Kollur SP
    Front Oncol; 2021; 11():822865. PubMed ID: 34988031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.
    Moosavi F; Giovannetti E; Saso L; Firuzi O
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):533-566. PubMed ID: 31512514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.
    Hou T; Jiang S; Wang Y; Xie Y; Zhang H; Feng Y; Ma F; Ma J; Liu X; Hu C
    Front Oncol; 2021; 11():705406. PubMed ID: 34150669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum to "Expression of HGF and c-Met Proteins in Human Keratoconus Corneas".
    You J; Wen L; Roufas A; Hodge C; Sutton G; Madigan MC
    J Ophthalmol; 2016; 2016():4201505. PubMed ID: 27610241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line.
    Nishimura Y; Takiguchi S; Ito S; Itoh K
    Int J Oncol; 2014 Feb; 44(2):412-26. PubMed ID: 24297483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
    Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
    Liu X; Zhou Z; Wang Y; Zhu K; Deng W; Li Y; Zhou X; Chen L; Li Y; Xie A; Zeng T; Wang G; Fu B
    Front Oncol; 2020; 10():1735. PubMed ID: 33014857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer.
    Tan S; Yi P; Wang H; Xia L; Han Y; Wang H; Zeng B; Tang L; Pan Q; Tian Y; Rao S; Oyang L; Liang J; Lin J; Su M; Shi Y; Liao Q; Zhou Y
    Front Oncol; 2020; 10():1106. PubMed ID: 32760669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum: Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease.
    Di Villeneuve L; Souza IL; Tolentino FDS; Ferrarotto R; Schvartsman G
    Front Oncol; 2021; 11():669486. PubMed ID: 33898325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications.
    Zorzetto M; Ferrari S; Saracino L; Inghilleri S; Stella GM
    Transl Lung Cancer Res; 2012 Sep; 1(3):194-207. PubMed ID: 25806181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.
    Abudoureyimu M; Lai Y; Tian C; Wang T; Wang R; Chu X
    Front Oncol; 2020; 10():701. PubMed ID: 32432043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study.
    Awad MM; Le Bruchec Y; Lu B; Ye J; Miller JA; Lizotte PH; Cavanaugh ME; Rode AJ; Dumitru CD; Spira A
    Front Oncol; 2022; 12():889996. PubMed ID: 35747830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MET and phosphorylated MET as potential biomarkers in lung cancer.
    Tretiakova M; Salama AK; Karrison T; Ferguson MK; Husain AN; Vokes EE; Salgia R
    J Environ Pathol Toxicol Oncol; 2011; 30(4):341-54. PubMed ID: 22181983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.